Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
dc.conference.date | SEP 16-21, 2021 | |
dc.conference.title | Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.contributor.author | Garcia Castano, A. | |
dc.contributor.author | Munoz Couselo, E. | |
dc.contributor.author | Soria, A. | |
dc.contributor.author | Lavernia, J. | |
dc.contributor.author | Sanmartin, O. | |
dc.contributor.author | Canueto, J. | |
dc.contributor.author | Ayala de Miguel, P. | |
dc.contributor.author | Bea Ardebol, S. | |
dc.contributor.author | Bellido Hernandez, L. | |
dc.contributor.author | Fernandez-de-Misa Cabrera, R. | |
dc.contributor.author | Cunquero-Tomas, A. J. | |
dc.contributor.author | Fernandez Franco, L. | |
dc.contributor.author | Fernandez-Freire Leal, A. | |
dc.contributor.author | Mujika Eizmendi, K. | |
dc.contributor.author | Ortiz, C. | |
dc.contributor.author | Redondo, P. | |
dc.contributor.author | Romero, I. | |
dc.contributor.author | Serrano Fernandez, M. | |
dc.contributor.author | Medina Martinez, J. | |
dc.contributor.authoraffiliation | [Garcia Castano, A.] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain | |
dc.contributor.authoraffiliation | [Serrano Fernandez, M.] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain | |
dc.contributor.authoraffiliation | [Munoz Couselo, E.] Hosp Valle De Hebron, Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Soria, A.] Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Lavernia, J.] Fdn Inst Valenciano Oncol IVO, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Sanmartin, O.] Fdn Inst Valenciano Oncol IVO, Dermatol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Canueto, J.] Complejo Asistencial Univ Salamanca, Dermatol, Salamanca, Spain | |
dc.contributor.authoraffiliation | [Ayala de Miguel, P.] Complejo Hospitalario Univ Caceres, Med Oncol, Caceres, Spain | |
dc.contributor.authoraffiliation | [Bea Ardebol, S.] Hosp Univ Ramon y Cajal, Dermatol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Bellido Hernandez, L.] Complejo Asistencial Univ Salamanca, Med Oncol, Salamanca, Spain | |
dc.contributor.authoraffiliation | [Fernandez-de-Misa Cabrera, R.] Hosp Univ Nuestra Senora Candelaria, Dermatol, Santa Cruz De Tenerife, Spain | |
dc.contributor.authoraffiliation | [Cunquero-Tomas, A. J.] Consorcio Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Fernandez Franco, L.] Hosp Virgen Salud, Med Oncol, Toledo, Spain | |
dc.contributor.authoraffiliation | [Medina Martinez, J.] Hosp Virgen Salud, Med Oncol, Toledo, Spain | |
dc.contributor.authoraffiliation | [Fernandez-Freire Leal, A.] Hosp Torrecardenas, Med Oncol, Almeria, Spain | |
dc.contributor.authoraffiliation | [Mujika Eizmendi, K.] UGC Oncol Gipuzkoa OSI Donostialdea Onkol, Med Oncol, Donostia San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Ortiz, C.] Vall dHebron Inst Oncol VHIO, Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Redondo, P.] Clin Univ Navarra, Dermatol, Pamplona, SpainInst Valenciano Oncol IVO, Med Oncol, Valencia, Spain | |
dc.contributor.funder | Sanofi | |
dc.date.accessioned | 2025-01-07T12:49:08Z | |
dc.date.available | 2025-01-07T12:49:08Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.doi | 10.1016/j.annonc.2021.08.1446 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753421036759/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/24953 | |
dc.identifier.wosID | 700527702079 | |
dc.issue.number | 5 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Torrecárdenas | |
dc.organization | SAS - Hospital Universitario Torrecárdenas | |
dc.page.number | S884-S884 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |